lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction

J Cardiovasc Transl Res. 2020 Dec;13(6):1008-1015. doi: 10.1007/s12265-020-10029-0. Epub 2020 May 21.

Abstract

Long non-coding RNAs (lncRNAs) are a new focus in cardiovascular diseases. The necrosis-related factor (NRF) is a newly discovered lncRNA, which is increased in myocardial injury. We investigated the role of lncRNA-NRF in heart failure (HF) after acute myocardial infarction (AMI) to find a biomarker for early HF detection. This was a cross-sectional study of 76 AMI patients with HF and 58 AMI patients without HF. lncRNA-NRF was shown to be increased in AMI patients with HF compared with AMI patients without HF and had predictive value for diagnosis of HF. It had a high diagnostic value for HF (AUC, 0.975), while the AUC for N-terminal pro-brain natriuretic peptide was 0.720. Our findings suggest that lncRNA-NRF may represent a marker of risk for development of HF post-AMI.

Keywords: Acute myocardial infarction; Diagnosis; Heart failure; lncRNA-NRF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Heart Failure / blood*
  • Heart Failure / diagnosis
  • Heart Failure / genetics
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / blood*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / genetics
  • Natriuretic Peptide, Brain / blood
  • Peptide Fragments / blood
  • Predictive Value of Tests
  • Prognosis
  • RNA, Long Noncoding / blood*
  • RNA, Long Noncoding / genetics

Substances

  • Biomarkers
  • Peptide Fragments
  • RNA, Long Noncoding
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain